Pleural effusion epidemiology and demographics: Difference between revisions
Gerald Chi (talk | contribs) ( : ) |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Pleural effusion}} | {{Pleural effusion}} | ||
{{CMG}} | |||
==Overview== | ==Overview== | ||
Revision as of 15:46, 16 May 2013
|
Pleural effusion Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pleural effusion epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Pleural effusion epidemiology and demographics |
|
Risk calculators and risk factors for Pleural effusion epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
In the United States, up to one million patients develop parapneumonic effusions annually, and approximately 100,000 patients undergo pleurodesis for recurrent pleural effusions per year.[1] Pleural effusion is reported to have an incidence of 0.32% in a study among the general population in central Bohemia. Congestive heart failure accounts for nearly 50% of cases, with malignancy, pneumonia and pulmonary emboli as the next three leading causes.[2] However, the distribution of causes is largely dependent on the population studied.
References
- ↑ Light, Richard J. (2007). Pleural diseases. Hagerstwon, MD: Lippincott Williams & Wilkins. ISBN 0-7817-6957-4.
- ↑ Marel M, Zrůstová M, Stasný B, Light RW (1993). "The incidence of pleural effusion in a well-defined region. Epidemiologic study in central Bohemia". Chest. 104 (5): 1486–9. PMID 8222812. Unknown parameter
|month=ignored (help)